
RadNet RDNT
€ 45.47
1.81%
Quartalsbericht 2026-Q1
hinzugefügt 11.05.2026
RadNet EV 2011-2026 | RDNT
EV Jährlich RadNet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.26 B | 5.09 B | 3.94 B | 3.12 B | 3.16 B | 2.42 B | 2.5 B | 1.54 B | 1.23 B | 1.05 B | 1.06 B | 1.06 B | 786 M | 833 M | 778 M | 723 M | 79.6 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.26 B | 79.6 M | 2.15 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
583 M | $ 19.5 | 7.5 % | $ 600 M | ||
|
Celcuity
CELC
|
5.57 B | $ 92.47 | 3.96 % | $ 4.32 B | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 5.76 | 11.41 % | $ 7.66 M | ||
|
Guardant Health
GH
|
15.2 B | $ 133.06 | 4.75 % | $ 16.7 B | ||
|
Castle Biosciences
CSTL
|
463 M | $ 21.6 | 5.93 % | $ 626 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
69.5 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 23.12 | 3.63 % | $ 1.23 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
16.5 B | $ 152.8 | 6.18 % | $ 12 B | ||
|
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 1.79 | 2.29 % | $ 7.92 M | ||
|
Illumina
ILMN
|
23.8 B | $ 168.06 | -1.68 % | $ 26 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
-2.71 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
3.34 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 102.82 | 2.56 % | $ 6.94 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 185.79 | 3.29 % | $ 9.21 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 180.48 | 0.95 % | $ 24.3 B | ||
|
Medpace Holdings
MEDP
|
14 B | $ 458.69 | 1.75 % | $ 13.2 B | ||
|
NeoGenomics
NEO
|
1.85 B | $ 11.31 | 11.54 % | $ 1.45 B | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Natera
NTRA
|
30.1 B | $ 222.1 | 4.84 % | $ 30.4 B | ||
|
National Research Corporation
NRC
|
432 M | $ 19.75 | 3.73 % | $ 442 M | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.69 | 6.59 % | $ 434 M | ||
|
Personalis
PSNL
|
380 M | $ 12.1 | 12.24 % | $ 1.08 B | ||
|
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 25.99 | 2.48 % | $ 24.6 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 7.01 | 4.32 % | $ 293 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.15 | 1.9 % | $ 4.94 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 260.97 | 0.79 % | $ 21.7 B | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 73.93 | 2.21 % | $ 4.42 B | ||
|
Thermo Fisher Scientific
TMO
|
186 B | $ 482.03 | 1.7 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
327 M | $ 0.68 | -2.4 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.12 | 3.52 % | $ 1.98 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 196.12 | 1.27 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
Waters Corporation
WAT
|
21.6 B | $ 376.47 | -0.87 % | $ 22.4 B |